Berlin-Frankfurt-Münster group. Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia - Meinhardt, A; Burkhardt, B; Zimmermann, M (J Clin Oncol, 2010)
et al.